| Authors | Patient sex | Age | Presenting symptoms | Primary site | Imaging identification of metastasis | Metastasis site | Treatment | Outcome |
| Tewari et al. [19] | Female | 47 | Rising serum chromogranin A on follow-up | Gallbladder | 18-FDG PET/CT | Left parietooccipital | RT | Survived |
|
Freedy and Miller [16] | Male | 63 | Generalized weakness, inappropriate language, jerking movements RUE and RLE | Prostate | Contrast-enhanced CT | Left hemisphere, periventricular | Chemotherapy, palliative measures | Died, 7 days later |
| Zachariah et al. [20] | Male | 72 | Confusion, unsteady gait, progressive difficulty talking | Prostate | Contrast-enhanced CT and MRI | Multiple cystic lesions, single right cerebellar hemisphere lesion | WBRT: 30 Gy in 10 treatments | Died, 6 weeks later |
| Isaka et al. [17] | Male | 67 | Increasing severity headache | Bladder | CT, T1 and T2, MRI | Cystic lesion left frontal lobe | STR, WBRT: 40 Gy in 20 fractions | Died, 4 months later |
| Erasmus et al. [15] | Male | 70 | Left homonymous hemianopsia | Prostate | CT and MRI | Right optic radiation | 20 Gy in 5 fractions, booster dose of 15 Gy in 5 doses | Died, 4 months later |
|
Madroszyk et al. [18] | Male | 69 | General fatigue, 5 kg weight loss | Esophagus | CT | Multiple metastasis | Not discussed | Died, 22 months later | Male | 48 | Confusion | Esophagus | CT | Multiple metastasis | RT and corticotherapy | Died, 10 months later |
|
Hussein et al. [21] | Female | 50 | Vertigo, ataxia, nausea, vomiting | Rectum | CT | Right cerebellar mass | SR, RT (3000 rads) | Survived | Male | 43 | Bifrontal headaches, stuporous, right hemiplegia | Colon | CT | Right frontal lobe, left basal ganglion, left subcortical frontal region | SR, RT (3000 rads) | Survived |
| Mallory et al. [22] | 10 M; 5 F | 58 (average) | Sensorimotor (6) headache (4), seizures, hydrocephalus, carcinoid syndrome (3) | Lung (7), stomach (4), pancreas (1), large intestine (2), thymus (1), kidney (2), unknown (1) | N/A | Brain | SR (12), GKS (2), WBRT (1) | 2 alive at last follow-up, median overall survival 19 months |
|
|